Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210160908> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3210160908 abstract "<p>Alzheimer's disease (AD) is the most common neurodegenerative disorder, yet the cause and progression of this disorder are not completely understood. While the main hallmark of AD is the deposition of amyloid plaques consisting of the β-amyloid (Aβ) peptide, transition metal ions are also known to play a significant role in disease pathology by expediting the formation of neurotoxic soluble β-amyloid (Aβ) oligomers, reactive oxygen species (ROS), and oxidative stress. Thus, bifunctional metal chelators that can control these deleterious properties are highly desirable. Herein, we show that amentoflavone (AMF) – a natural biflavonoid compound, exhibits good metal-chelating properties, especially for chelating Cu<sup>2+</sup> with very high affinity (pCu<sub>7.4</sub> = 10.44). In addition, AMF binds to Aβ fibrils with a high affinity (<i>K<sub>i</sub></i> = 287 ± 20 nM) – as revealed by a competition thioflavin T (ThT) assay, and specifically labels the amyloid plaques <i>ex vivo</i> in the brain sections of transgenic AD mice – as confirmed via immunostaining with an Ab antibody. The effect of AMF on Aβ<sub>42</sub> aggregation and disaggregation of Aβ<sub>42</sub> fibrils was also investigated, to reveal that AMF can control the formation of neurotoxic soluble Aβ<sub>42</sub> oligomers, both in absence and presence of metal ions, and as confirmed via cell toxicity studies. Furthermore, an ascorbate consumption assay shows that AMF exhibits potent antioxidant properties and can chelate Cu<sup>2+</sup> and significantly diminish the Cu<sup>2+</sup>-ascorbate redox cycling and reactive oxygen species (ROS) formation. Overall, these studies strongly suggest that AMF acts as a bifunctional chelator that can interact with various Aβ aggregates and reduce their neurotoxicity, can also bind Cu<sup>2+</sup> and mediate its deleterious redox properties, and thus AMF has the potential to be a lead compound for further therapeutic agent development for AD. </p>" @default.
- W3210160908 created "2021-11-08" @default.
- W3210160908 creator A5007162236 @default.
- W3210160908 creator A5021486550 @default.
- W3210160908 creator A5022058887 @default.
- W3210160908 creator A5060196178 @default.
- W3210160908 date "2020-06-09" @default.
- W3210160908 modified "2023-09-26" @default.
- W3210160908 title "Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ42 Oligomers" @default.
- W3210160908 doi "https://doi.org/10.26434/chemrxiv.12445505.v1" @default.
- W3210160908 hasPublicationYear "2020" @default.
- W3210160908 type Work @default.
- W3210160908 sameAs 3210160908 @default.
- W3210160908 citedByCount "0" @default.
- W3210160908 crossrefType "posted-content" @default.
- W3210160908 hasAuthorship W3210160908A5007162236 @default.
- W3210160908 hasAuthorship W3210160908A5021486550 @default.
- W3210160908 hasAuthorship W3210160908A5022058887 @default.
- W3210160908 hasAuthorship W3210160908A5060196178 @default.
- W3210160908 hasBestOaLocation W32101609081 @default.
- W3210160908 hasConcept C12554922 @default.
- W3210160908 hasConcept C126322002 @default.
- W3210160908 hasConcept C161790260 @default.
- W3210160908 hasConcept C178790620 @default.
- W3210160908 hasConcept C179104552 @default.
- W3210160908 hasConcept C185592680 @default.
- W3210160908 hasConcept C197404232 @default.
- W3210160908 hasConcept C2776151105 @default.
- W3210160908 hasConcept C2776268974 @default.
- W3210160908 hasConcept C2777633098 @default.
- W3210160908 hasConcept C2778896982 @default.
- W3210160908 hasConcept C2779134260 @default.
- W3210160908 hasConcept C2780443040 @default.
- W3210160908 hasConcept C48349386 @default.
- W3210160908 hasConcept C502032728 @default.
- W3210160908 hasConcept C55493867 @default.
- W3210160908 hasConcept C71924100 @default.
- W3210160908 hasConcept C86803240 @default.
- W3210160908 hasConceptScore W3210160908C12554922 @default.
- W3210160908 hasConceptScore W3210160908C126322002 @default.
- W3210160908 hasConceptScore W3210160908C161790260 @default.
- W3210160908 hasConceptScore W3210160908C178790620 @default.
- W3210160908 hasConceptScore W3210160908C179104552 @default.
- W3210160908 hasConceptScore W3210160908C185592680 @default.
- W3210160908 hasConceptScore W3210160908C197404232 @default.
- W3210160908 hasConceptScore W3210160908C2776151105 @default.
- W3210160908 hasConceptScore W3210160908C2776268974 @default.
- W3210160908 hasConceptScore W3210160908C2777633098 @default.
- W3210160908 hasConceptScore W3210160908C2778896982 @default.
- W3210160908 hasConceptScore W3210160908C2779134260 @default.
- W3210160908 hasConceptScore W3210160908C2780443040 @default.
- W3210160908 hasConceptScore W3210160908C48349386 @default.
- W3210160908 hasConceptScore W3210160908C502032728 @default.
- W3210160908 hasConceptScore W3210160908C55493867 @default.
- W3210160908 hasConceptScore W3210160908C71924100 @default.
- W3210160908 hasConceptScore W3210160908C86803240 @default.
- W3210160908 hasLocation W32101609081 @default.
- W3210160908 hasLocation W32101609082 @default.
- W3210160908 hasOpenAccess W3210160908 @default.
- W3210160908 hasPrimaryLocation W32101609081 @default.
- W3210160908 hasRelatedWork W2070801111 @default.
- W3210160908 hasRelatedWork W2077200845 @default.
- W3210160908 hasRelatedWork W2235224040 @default.
- W3210160908 hasRelatedWork W2320739632 @default.
- W3210160908 hasRelatedWork W2529551069 @default.
- W3210160908 hasRelatedWork W2590318250 @default.
- W3210160908 hasRelatedWork W2591045712 @default.
- W3210160908 hasRelatedWork W3107733841 @default.
- W3210160908 hasRelatedWork W3131798545 @default.
- W3210160908 hasRelatedWork W4200535075 @default.
- W3210160908 isParatext "false" @default.
- W3210160908 isRetracted "false" @default.
- W3210160908 magId "3210160908" @default.
- W3210160908 workType "article" @default.